Nautilus Biotechnolgy, Inc. (NAUT) Stock Score, Valuation & Financial Research

Nautilus Biotechnolgy, Inc. is in the Healthcare sector and Biotechnology industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for NAUT

Nautilus Biotechnolgy, Inc. does not currently have a complete Wall Street Score. The stored market price is USD 2.05. These figures are a research snapshot, not a buy or sell recommendation.

What Nautilus Biotechnolgy, Inc. does

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

Nautilus Biotechnology is a development-stage company focused on creating a single-molecule proteome analysis platform. The company currently generates no significant revenue from product sales and relies on capital raised from investors to fund its research, development, and early-access commercialization efforts.

Products and services

  • The company is developing the Nautilus Proteome Analysis Platform, which is designed to identify and quantify the human proteome at the single-molecule level.

Brands and product families

  • Nautilus Proteome Analysis Platform — The primary technology platform under development by the company. Source

Customer types

Academic research institutions; Biopharmaceutical organizations.

Suppliers, materials and equipment

  • Contract manufacturing and specialized component suppliers — The company relies on third-party suppliers for the manufacturing of components and instruments required for its platform development. Source

Competitors and product-market comparisons

  • Proteomics and genomics technology companies — Companies developing alternative platforms for protein analysis, mass spectrometry, and next-generation sequencing. Source

Business strengths to evaluate

  • Proprietary single-molecule proteome analysis technology Source

Business risks and research considerations

  • History of operating losses and potential inability to achieve profitability Source
  • Dependence on successful development and commercialization of the platform Source

Sources: Company research source

Company research refreshed 2026-10-12. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

NAUT financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 2.05
Market capitalization:
260.87M (currency not supplied)
Revenue:
USD 190K
Net income:
USD -56.52M
Free cash flow:
USD -51.97M
Cash:
USD 13.17M
Total debt:
USD 27.82M
EPS:
USD -0.45

What stands out

  • Free cash flow is USD -51.97M, negative for the stored period.
  • The balance sheet shows USD 13.17M of cash versus USD 27.82M of total debt, with debt exceeding cash on these two reported measures.
  • The current research record carries a missing revenue history warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Debt exceeds cash by USD 14.65M using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for NAUT

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • How long can NAUT fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • Is NAUT's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • What specifically needs to improve for NAUT to reach sustainable profitability?
  • What does the current missing revenue history warning mean for the reliability or interpretation of NAUT's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-08.

Research-input completeness: 73% of the scoring inputs required for this public page are currently available.

How to research NAUT

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.